heart failure

News

Clear COVID health information essential for a return to healthcare as normal

Pharma poised to cash in on 'long COVID' symptoms

While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time.

News

FDA approves Bayer/Merck & Co heart failure drug

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market.

News

Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga wi...

Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabe

News

NICE backs AZ’s Forxiga for heart failure

Just a few weeks after its EU approval for heart failure, AstraZeneca’s Forxiga has been backed by NICE for this use by the NHS in England and Wales.

News

Entresto set for big sales hike after FDA panel endorsement

Novartis’ Entresto is on course to become the first drug to be approved in the US for a form of heart failure that is notoriously hard to treat effectively, despite missing the mark in a ph

News

AZ's Q3 results disappoint - but COVID-19 vaccine trial is s...

AstraZeneca has posted an uninspiring set of quarterly results as it gears up for results from its closely watched coronavirus vaccine trial.

Pharma poised to cash in on 'long COVID' symptoms

FDA approves Bayer/Merck & Co heart failure drug

Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga wi...

NICE backs AZ’s Forxiga for heart failure

Entresto set for big sales hike after FDA panel endorsement

AZ's Q3 results disappoint - but COVID-19 vaccine trial is s...

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

heart failure

Editor's Picks